# SPECTRUM PHARMACEUTICALS INC: Form D filings

SPECTRUM PHARMACEUTICALS INC, a pharmaceuticals company in Henderson, NV, filed 2 Form D notices with the SEC between 2013 and 2016. The latest, on April 28, 2016, reports $3 million sold of a $3 million offering to 1 investor.

Find out what SPECTRUM PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20SPECTRUM%20PHARMACEUTICALS%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=SPECTRUM%20PHARMACEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fspectrum-pharmaceuticals-inc-831547)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20SPECTRUM%20PHARMACEUTICALS%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=SPECTRUM%20PHARMACEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fspectrum-pharmaceuticals-inc-831547)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Nevada](https://specstream.ai/data/form-d/state/nevada): 610 rows, by operating companies, filed since November 1, 2024, $30.50, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/nevada
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 11500 S. EASTERN AVE., SUITE 240, Henderson, NV, 89052
- Phone: (702) 835-6300
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 831547

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 28, 2016 | New notice | $3,000,000 | $3,000,000 | $0 | 1 | Apr 26, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/831547/000083154716000064/0000831547-16-000064-index.htm) |
| Jul 31, 2013 | New notice | $27,500,000 | $27,500,000 | $0 | 4 | Jul 17, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/831547/000083154713000001/0000831547-13-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Anthony E. Maida | Director |  |
| Gilles R. Gagnon | Director |  |
| Stuart M. Krasner | Director |  |
| Luigi M. Lenaz | Director |  |
| Rajesh C. Shrotriya | Executive Officer, Director |  |
| Raymond W. Cohen | Director |  |
| Kurt A. Gustafson | Executive Officer |  |
| Joseph W. Turgeon | Executive Officer |  |
| Dolatrai R. Vyas | Director |  |

[Every Form D from the week of Apr 25, 2016](https://specstream.ai/data/form-d/week/2016-04-25) · [All recent filings in Nevada](https://specstream.ai/data/form-d/state/nevada) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what SPECTRUM PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).